Mjstocks
No Need To Overcomplicate ThisMy key level is $13 which we broke in after hours. If it continues to rally $15 is a very realistic/conservative target. If we get more positive news this will easily get to $20. Very bullish on this pattern as well.
SNDL under new AdministrationPossible ideas for SNDL. New administration coming into power. If Harris stays true to her word(unlike she usually does) she will make marijuana legal as one of the first things she does in office. should see jump in MJ stocks short term. possible long term but black market will always be#1 unless you can buy weed like beer in your corner stores
CRON primary count establishingI am still looking at the MJ sector as a whole needing to see more upside soon. Right now I think we could still be just establishing a 3rd wave, and I could see it continuing up from here. However if we continue to break down and need to make another 12 or another count becomes clear we have a nice support zone sitting on the breakout.
Cannabis Strategic Ventures - $NUGS Weekly ChartNuG$ acts as a holding company developing a portfolio of profitable subsidiaries operating in the legalized cannabis industry. They only operate in those states where cannabis is legalized and regulated under applicable state laws, and/or has been de-criminalized for medical use and/or legalized for recreational use. Currently, their subsidiary holdings are considered non-operational.
$NUGS subsidiaries include:
● Pure Applied Sciences, Inc., a Delaware corporation engaged in the marketing and sales of its “PureOrganics™” brand of cannabis oils and related accessories;
● Fitamins, Inc., a Wyoming corporation, engaged in the marketing and sale of a brand of health and wellness products containing hemp-based CBD; and,
● Lyxr™, a brand of based luxury skin, hair and body products containing hemp-based CBD and other Phyto cannabinoids and other natural ingredients providing high-performing skin, hair and body topical solutions; and,
● BudHire, a staffing solution brand operating in Washington and California that provides temporary, long term and permanent staffing solutions for the Cannabis industry; and,
● NUGS Farm North owns 16 cannabis cultivation licenses, one nursery license, one distribution license, and one processing license in Northern California.
● FLORAH, a CBD only retail store conceptualized for launch in Los Angeles.
Resources
cannabisstrategic.com
cannabisstrategic.com
www.sec.gov
Important Notes below
www.sec.gov
Results of Operations
For the three months ended June 30, 2020 compared to fiscal year ended June 30, 2019.
Revenues and Cost of Revenues
Total revenues were $3,372,537 for the three months ended June 30, 2020 as compared to $161,158 for the three months ended June 30, 2019, an increase of $3,211,379. The increase in revenues was due to our sales from sale of Cannabis products and income from BudHire staffing services. Cost of revenues were $2,477,285 or 73.45% of total revenues for the three months ended June 30, 2020, versus $184,234 or 114.32% of total revenues for the three months ended June 30, 2019. This increase in costs of sales was due to our BudHire operations, whereby we invoice our staffing clients, who pay us a fee, and we account for the costs of paying placed employees for the staffing services provided and the cost to grow and harvest the cannabis in NUGS Farm North.
Gross Profit
Total gross profit was $895,252 for the three months ended June 30, 2020. This compares to total gross loss of $(23,076) for the three months ended June 30, 2019. Total gross profits for the three months ended June 30, 2020 as compared to 2019 reflect an increase of $918,328.
Operating Expenses
Total operating expenses were $2,312,505, for the three months ended June 30, 2020, as compared to $2,104,115 for the three months ended June 30, 2019. This increase was primarily due to more leases expense in the NUGS Farm North for the three months ended June 30, 2020.
Other Income (Expense)
Other income (expense) for the three months ended June 30, 2020 was income of $19,906 as compared with expense of ($187,544) for the three months ended June 30, 2019. This decrease in expense was due to reduction in loss in investing activity.
Net Income (Loss)
As a result of the factors discussed above, loss for the three months ended June 30, 2020 was ($1,420,032) as compared to a loss for the three months ended June 30, 2019 of ($2,308,156).
Lower net-loss from 2019 which is a good sign
Results of Operations
For the fiscal year ended March 31, 2020 compared to fiscal year ended March 31, 2019.
Revenues and Cost of Revenues
Total revenues were $2,367,367 for the year ended March 31, 2020 as compared to $701,968 for the year ended March 31, 2019, an increase of $1,665,399. The increase in revenues was due to our sales from sale of Cannabis products and income from BudHire staffing services. Cost of revenues were $1,890,496 or 79.86% of total revenues for the year ended March 31, 2020, versus $680,917 or 97% of total revenues for the year ended March 31, 2019. This increase in costs of sales was due to our BudHire operations, whereby we invoice our staffing clients, who pay us a fee, and we account for the costs of paying placed employees for the staffing services provided and the cost to grow and harvest the cannabis in NUGS Farm North.
Solid growth in Revenues atleast they are proving they can make the $$$
Gross Profit
Total gross profit was $476,871 for the year ended March 31, 2020. This compares to total gross profit of $21,051 for the year ended March 31, 2019. Total gross profits for the year ended year ended March 31, 2020 as compared to 2019 reflect an increase of $455,820.
Operating Expenses
Total operating expenses were $9,053,806, for the year ended March 31, 2020, as compared to $21,136,801 for the year ended March 31, 2019. This decrease was primarily due to decrease in stock compensation expense of $1,471,277 for the year ended March 31, 2020 compare to $19,341,321 for the year ended March 31, 2019. Also, the Company incurred more leases expense in the NUGS Farm North for the year ended March 31, 2020.
Other Income (Expense)
Other income (expense) for the year ended March 31, 2020 was expense of ($461,456) as compared with expense of ($319,615) for the year ended March 31, 2019. This increase in expense was due to a loss in investing activity.
Net Income (Loss)
As a result of the factors discussed above, loss for the year ended March 31, 2020 was ($9,079,609) as compared to a loss for the year ended March 31, 2019 of ($21,432,605).
This is a HUGE plus, the fact they lowered their net-loss from 21mil down to 10mil is a great sign lookingforward.
Liquidity and Capital Resources
As of June 30, 2020, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $456,630, accounts receivable of $947,898, inventory of $2,955,039, and other receivables of $82.646. We have, during the period ended June 30, 2020, relied upon external financing arrangements to fund our operations. During the period ended June 30, 2020, we entered into several separate financing arrangements, to fund our Northern California cannabis grow and cultivation operation. Our ability to rely upon external financing arrangements to fund operations is not certain, and this may limit our ability to secure future funding from external sources without changes in terms requested by counterparties, changes in the valuation of collateral, and associated risk, each of which is reasonably likely to result in our liquidity decreasing in a material way. We intend to utilize cash on hand, loans and other forms of financing such as the sale of additional equity and debt securities and other credit facilities to conduct our ongoing business, and to also conduct strategic business development and implementation of our business plans generally.
Our ability to timely complete our payment commitments is contingent upon our having to raise additional capital, which is not certain. Our ability to access additional funding through external financing arrangements is uncertain, and could possibly include terms and conditions pertaining to the valuation of collateral and associated risk, each of which is reasonably likely to result in our liquidity decreasing in a material way.
For the three months ended June 30, 2020 compared to fiscal year ended June 30, 2019.
Operating Activities
Net cash used by operating activities for the three months ended June 30, 2020 was a use of ($1,348,691) and ($429,287) for the three months ended June 30, 2019.
Investing Activities
For the three months ended June 30, 2020 and 2019, investing activities were a use of cash of ($6,478) and ($2,735,147) respectively.
Financing Activities
For the three months ended June 30, 2020 and 2019, the net cash from financing activities was $1,323,335 and $3,304,601 respectively.
For the fiscal year ended March 31, 2020 compared to fiscal year ended March 31, 2019.
Operating Activities
Net cash used by operating activities for the year ended March 31, 2020 was a use of ($7,642,740) and ($2,531,612) for the year ended March 31, 2019.
Investing Activities
For the years ended March 31, 2020 and 2019, investing activities were a use of cash of ($3,402,893) and ($144,200) respectively.
Financing Activities
For the years ended March 31, 2020 and 2019, the net cash from financing activities was $11,459,428 and $2,346,976 respectively.
Off Balance Sheet Arrangements
As of June 30, 2020 and March 31, 2020, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
Shares Reclass
During the year ended March 31, 2020, the Company issued 7,277,856 shares to employees and non-employees for their stock compensation accrued as of March 31, 2019.
Going Concern
The Company sustained continued operating losses during the three months ended June 30, 2020 and 2019. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations, in which it has not been successful, and/or obtaining additional financing from its shareholders or other sources, as may be required.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $46.9 million at June 30, 2020, and net loss of $1.4 million for the three months ended June 30, 2020. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern.
All in All if your still reading, I see potential for $NUGS to spike higher on the weekly. Still take profits when you see those narly gains! Acucumulation zone: .002500-->.10 Looking for a decent swing higher in the coming months. GLTA & may the NUGZ BE WITH US$
$SNDL Major Earnings Beat TBH IMO PT $1.50+Sundial Growers , Inc. engages in the production and distribution of flower, pre-rolls and vapes. It operates through the following segments: Cannabis, Ornamental Flowers, and Corporate.
Aug 13 (Reuters): NET CANNABIS REVENUE FOR Q2 OF 2020 WAS $20.2 MILLION, AN INCREASE OF 44% OVER Q1 OF 2020
6/29/2020 BMO Capital Markets Upgrade Underperform ➝ Market Perform target price $1.00
If we divide the equity value or total value which is the sum of the present value of the future cash flows, which in this case is CA$282m by the number of shares outstanding relative to the current share price we get a valuation
of .75 which in my opinion is still highly undervalued.
The company's goal is to provide customers with the best quality cannabis with the help of experts in the growing field.
The company’s partners include the University of Saskatchewan, University of Calgary, Inplanta Biotechnology, PlantBiosis, Town of Olds and Olds College.
Sundial Growers operates several different brands that it sells its cannabis products through.
That includes Sundial, Top Leaf, BC Weed Co., Palmetto, and Grasslands.
"CALGARY, AB, Nov. 9, 2020 /PRNewswire/ - Sundial Growers Inc. ("Sundial" or the "Company"), is pleased to announce that it has entered into a sales and distribution agreement (the "Agreement") with local company Choklat Inc. ("Choklat"), a Health Canada licensed chocolatier company focused on offering decadent confections with high-quality flavour. The new collaboration between the two Alberta-based companies provides Sundial the opportunity to continue to expand its product portfolio and enter the edible market."
"CALGARY, AB, Oct. 20, 2020 /PRNewswire/ - Sundial Growers Inc. (NASDAQ: SNDL) ("Sundial" or the "Company"), is pleased to announce the expansion of its Palmetto brand presence across Canada.cConsistent with Sundial's focus on premium inhalables, the Palmetto brand offers a diverse product portfolio to accommodate consumers looking for an experience that offers convenient, high-quality products alongside unique branding. Palmetto's dried flower format recently launched in Quebec and was sold out within two weeks, indicating early resonance with consumers in a rapidly expanding and competitive market."
My own PT around $3 by EOM
Does HMMJ.CA break up or down? Here's a short term chart for Horizons Medical MJ. It's been trying to base over the last week, with some continued follow-through, albeit timid. I expect we're winding up to the #More vote scheduled for the week of September 21st. For me, it's a coin toss. The overall trend is clearly bearish, but it's certainly putting up a fight to reverse that.
ACB Strong Buy Signal w/ High Upside Potential next 6 monthsAurora Cannabis (ACB) closed at $6.98 on Sept 11, meeting 2 previous support Lows.
Fibonacci ratios and Elliot Waves on this chart fit quite nicely.
Key points for a BULLish trend over the next 6 months:
Key Support met again. History tells us a breakout may be on the horizon.
Declining volume on the downward trade indicates a possibility for a breakout with high volume.
RSI provides a strong oversold indicator.
Consider the larger Elliot Wave Trend and see that we may be at the low of a Wave 2 on the larger cycle, indicating the best buying opportunity of all time, with low downside risk.
Key Points for Risk-Reward Trades over the shorter-term:
Note the MACD cross-over, but also the unreliable nature of this indicator, especially considering prior history of "flip-flopping".
Lots of opportunity to trade the up and down moves to $150 over the short term if there is a bull breakout.
First target of $33.50 is based on the .786 retracement, and coincides with the impulse peak of wave 3. This will require a strong breakout with volume and likely be accompanied by high volatility.
Disclaimer: I am not a professional and I chart for my own education and learning. Please feel free to share your ideas and any resources you might recommend! Thank you! :)